Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-52,500
Closed -$289K – 561
2025
Q3
$289K Buy
+52,500
New +$285K 0.01% 405
2025
Q1
– Sell
-580,700
Closed -$2.94M – 473
2024
Q4
$2.94M Buy
580,700
+310,700
+115% +$1.72M 0.08% 243
2024
Q3
$1.86M Buy
+270,000
New +$1.59M 0.05% 234
2023
Q1
– Sell
-105,000
Closed -$299K – 357
2022
Q4
$299K Buy
+105,000
New +$178K 0.01% 291
2020
Q3
– Sell
-30,000
Closed -$208K – 304
2020
Q2
$208K Buy
+30,000
New +$209K 0.01% 250

Other funds holding ARDX

J. Goldman & Co's ARDX Position: Q2 2026 in Review

J. Goldman & Co reduced its Ardelyx (ARDX) stake by 47% in Q2 2026, selling an estimated $8.67M and leaving 1,579,828 shares worth $8.06M. The position accounts for 0.21% of the portfolio, ranked #129.

J. Goldman & Co first reported a position in ARDX in Q4 2019 and has held it in 14 quarters since. The position peaked at $18M in Q1 2026. 250 funds tracked by Wall St. Rank hold ARDX as of Q2 2026.

  • J. Goldman & Co held 1,579,828 shares of Ardelyx worth $8.06M as of Q2 2026.
  • J. Goldman & Co sold 1,420,685 Ardelyx shares in Q2 2026, an estimated $8.67M.
  • Ardelyx made up 0.21% of J. Goldman & Co's portfolio in Q2 2026, its #129 holding.
  • J. Goldman & Co first reported a position in Ardelyx in Q4 2019 and has held it in 14 quarters since.
  • J. Goldman & Co's Ardelyx position peaked at $18M in Q1 2026.
  • 250 funds tracked by Wall St. Rank held Ardelyx as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.